资讯

Experimental Compound Offers Potential Treatment for Rare, Often Fatal Childhood Disease
The value of a recent biochemical discovery can be seen in the case of an 8-year-old boy, who was playing typical sports in ...
CoRegen, Inc. Closes More Than $93 Million Financing
Proceeds to support key development milestones, including CMC advancement, initiation of a Phase I clinical trial in the first half of 2026, and strategic expansion of the leadership teamHOUSTON, July ...